Jump Financial
IBRX icon

Jump Financial’s ImmunityBio IBRX Stock Holding History

Jump Financial’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.58M Buy
+485,476
New +$3.88M 0.03% 638
2026
Q2 		– Sell
-302,700
Closed -$2.32M – 2223
2026
Q1 		$2.32M Buy
302,700
+292,168
+2,774% +$2M 0.03% 599
2025
Q4 		$20.9K Buy
+10,532
New +$23.9K ﹤0.01% 1882
2023
Q3 		– Sell
-22,635
Closed -$62.9K – 2020
2023
Q2 		$62.9K Buy
+22,635
New +$64K ﹤0.01% 1712
2023
Q1 		– Sell
-16,900
Closed -$85.7K – 1789
2022
Q4 		$85.7K Buy
+16,900
New +$92.8K ﹤0.01% 1447
2022
Q2 		– Sell
-21,900
Closed -$123K – 1797
2022
Q1 		$123K Buy
21,900
+10,940
+100% +$67.1K 0.01% 1389
2021
Q4 		$66K Sell
10,960
-118,640
-92% -$891K ﹤0.01% 1279
2021
Q3 		$1.26M Buy
129,600
+13,857
+12% +$152K 0.09% 245
2021
Q2 		$1.65M Buy
115,743
+91,305
+374% +$1.51M 0.16% 153
2021
Q1 		$580K Buy
+24,438
New +$634K 0.05% 364
2020
Q4 		– Sell
-44,500
Closed -$309K – 1047
2020
Q3 		$309K Buy
+44,500
New +$444K 0.06% 485

Other funds holding IBRX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Jump Financial's IBRX Position: Q3 2026 in Review

Jump Financial opened a new position in ImmunityBio (IBRX) in Q3 2026: 485,476 shares worth $4.58M. The stake represents 0.03% of the portfolio and ranks #638 among its holdings. This is a return to the name: Jump Financial previously reported a position in IBRX as recently as Q1 2026.

Jump Financial first reported a position in IBRX in Q3 2020 and has held it in 11 quarters since. 321 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Jump Financial held 485,476 shares of ImmunityBio worth $4.58M as of Q3 2026.
  • ImmunityBio was a new Jump Financial position in Q3 2026.
  • ImmunityBio made up 0.03% of Jump Financial's portfolio in Q3 2026, its #638 holding.
  • Jump Financial first reported a position in ImmunityBio in Q3 2020 and has held it in 11 quarters since.
  • 321 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.